Uncategorized

Paratek Pharmaceuticals is betting that OptiNose’s chronic rhinosinusitis treatment will be a partner to its antibiotic treatment Nuzyra.

The deal is the latest in a series of Sanofi investments in its immunology portfolio. According to Sanfoi, DR-0201 can achieve deep B cell depletion, giving it the potential to reset the immune system.

After Sarepta reported the death of a patient who had recently taken the gene therapy Elevydis, patient advocacy group Parent Project Muscular Dystrophy stepped up—as they always do.

Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.

A group of medical experts expressed concern about growing “disinformation” and “misinformation,” calling for adherence to recommended vaccine schedules.

The Supreme Court last year blocked a previous settlement proposal from Purdue, arguing that the plan would afford the Sackler family too much protection.

Nearly half of BioSpace poll respondents recently took a biopharma job they were overqualified for, a finding that didn’t surprise a talent acquisition expert, who said it’s become much more likely to happen.

Learn about making the most of interview feedback, navigating bonus clawbacks and networking for niche roles.

Democratic senators from Georgia, Oregon, Maryland and New Mexico called the Trump administration’s decision to terminate hundreds of CDC staffers reckless and unfair.

La aterosclerosis y sus consecuencias son una de las principales causas de mortalidad de la población adulta. Esta patología consiste en la acumulación progresiva de colesterol y células inflamatorias en la pared arterial dando lugar a la placa aterosclerótica que, …